|
Cambrios
Technologies Corp. (formerly named Semzyme, Inc.)
was co-founded by Dr. Angela Belcher of MIT, one of
the world¹s premier materials scientists, and
Dr. Evelyn Hu of UCSB, a renowned electrical and computer
engineer.
Belcher¹s groundbreaking
technology featured in Science, Nature, The New York
Times, Forbes, and US News & World Report borrows
techniques from drug-discovery, genetic engineering
and materials science to self-assemble atomic-scale
wires and other electro-magnetic structures out of
inorganic materials, including semiconductors.
In commercializing Belcher¹s
inventions, Cambrios seeks to enable the production
of cheaper, better electronics via potentially non-toxic
manufacturing methods. But that¹s just one possibility
for the company¹s pioneering technology platform.
Since Cambrios can control the assembly of virtually
any material at the nano-scale, in a wide variety
of shapes and uniform sizes, the technology can be
applied throughout the electronics and chemical industries.
Cambrios
has also hired Michael R. Knapp as its first CEO.
Knapp was formerly the co-founder and CEO of Caliper
Life Sciences (a Nasdaq public company). Cambrios
also announced it has received $1.8 million in funding
from ARCH Ventures, Alloy Ventures and Oxford Biosciences.
The company has licensed its fundamental directed-evolution
technology from the University of Texas and Dyax Corp.
For more information contact:
Todd Stein
For Cambrios Technologies Corp.
Antenna Group Public Relations
San Francisco
415.990.5178
todd@antennagroup.com
|
